Author

V. Slaninova

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Djiane· 2 shared D. Kantar· 2 shared L. Heron-Milhavet· 2 shared A. Maraver· 1 shared B. Orsetti· 1 shared C. Benistant· 1 shared C. Geminard· 1 shared C. Gongora· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Djiane

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in colon cancer cells

V. Slaninova, L. Heron-Milhavet, M. Robin, L. Jeanson, D. Kantar, D. Tosi, L. Berhelin, C. Gongora, A. Djiane

The paper shows that TAZ/WWTR1 promotes oxaliplatin sensitivity in colon cancer cells through nuclear accumulation, independent of P73 but requiring DNA damage and P53 activity.

bioRxiv · Mar 17, 2023 · PreprintCancer Biology

MAGI1 inhibits the AMOTL2/p38 stress pathway and prevents luminal breast tumorigenesis

D. Kantar, E. Bousquet Mur, M. Mancini, V. Slaninova, Y. Ben Salah, L. Costa, E. Forest, P. Lassus, C. Geminard, F. Boissiere-Michot, B. Orsetti, C. Theillet, J. Colinge, C. Benistant, A. Maraver, , A. Djiane

The paper shows that MAGI1 loss in luminal breast cancer promotes tumorigenesis by activating the AMOTL2/p38 stress pathway, which is inhibited by MAGI1.

bioRxiv · Jun 13, 2020Cancer Biology